搜尋
Universe Pharmaceuticals Inc
UPC添加自選
3.170USD
-0.310-8.91%
收盤 07-31 16:00（美東）報價延遲15分鐘
1.79M總市值
0.00本益比TTM
關於 Universe Pharmaceuticals Inc 公司
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Universe Pharmaceuticals Inc簡介
公司代碼UPC
公司名稱Universe Pharmaceuticals Inc
上市日期Mar 23, 2021
CEOLai (Gang)
員工數量225
證券類型Ordinary Share
年結日Mar 23
公司地址265 Jingjiu Avenue
城市JI'AN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編343100
電話867968403309
網址http://www.universe-pharmacy.com/
公司代碼UPC
上市日期Mar 23, 2021
CEOLai (Gang)
Universe Pharmaceuticals Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
71.89K
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
IR Contact Officer
IR Contact Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
71.89K
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
常見問題
Universe Pharmaceuticals Inc的前五大股東是誰？
Universe Pharmaceuticals Inc的前五大股東如下：Mr. Gang Lai
有多少機構持有Universe Pharmaceuticals Inc(UPC)的股份？
截至2026Q1，共有15家機構持有Universe Pharmaceuticals Inc的股份，合計持有的股份價值約為28.11K，占公司總股份的5.02% 。與2025Q4相比，機構持股有所增加，增幅為18652.00。
哪個業務部門對Universe Pharmaceuticals Inc的收入貢獻最大？
在2026Q1，Sales of TCMD products業務部門對Universe Pharmaceuticals Inc的收入貢獻最大，創收13.26M，占總收入的74.25% 。